Epic Pharma, LLC – FDA 483, Feb 1, 2019
An FDA inspection of Epic Pharma, LLC in Laurelton, NY, revealed multiple significant deficiencies across its manufacturing operations. The firm failed to adequately validate manufacturing processes and cleaning procedures, ensure drug product conformity through proper testing, and maintain its water systems and environmental controls. Additionally, issues were noted with equipment calibration and the storage conditions for drug products, indicating a broad lack of adherence to quality standards.
ID · a5f59299-0cb4-4673-aade-4753d575ecd8
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.